Mayukh Sukhatme
2021
In 2021, Mayukh Sukhatme earned a total compensation of $17.5M as President and Chief Investment Officer at Roivant Sciences Ltd..
Compensation breakdown
| Bonus | $441,000 |
|---|---|
| Option Awards | $16,578,239 |
| Salary | $450,000 |
| Other | $19,186 |
| Total | $17,488,425 |
Sukhatme received $16.6M in option awards, accounting for 95% of the total pay in 2021.
Sukhatme also received $441K in bonus, $450K in salary and $19.2K in other compensation.
Rankings
In 2021, Mayukh Sukhatme's compensation ranked 412th out of 12,406 executives tracked by ExecPay. In other words, Sukhatme earned more than 96.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 412 out of 12,406 | 97th |
Division Manufacturing | 128 out of 5,494 | 98th |
Major group Chemicals And Allied Products | 37 out of 2,369 | 98th |
Industry group Drugs | 32 out of 2,090 | 99th |
Industry Pharmaceutical Preparations | 18 out of 1,537 | 99th |
Source: SEC filing on July 26, 2022.
Sukhatme's colleagues
We found two more compensation records of executives who worked with Mayukh Sukhatme at Roivant Sciences Ltd. in 2021.